|
As reported, during a balloon dilation of the "left pyelo-ureteral schedule", an advance 18 lp low profile balloon catheter separated.The balloon was advanced over another manufacturer's guidewire and through another manufacturer's cystoscope through the urethra.Another manufacturer's catheter was used for contrast introduction.The balloon was inflated in the left skyle-ureteral junction to fourteen atmospheres one time for three minutes.Once the balloon was completely deflated and returned to ambient pressure, a counterclockwise rotation was used to remove the balloon while maintaining negative pressure.The removal was controlled with microscopy (x-ray).Upon reaching the uretero-vesical junction, the user encountered problems/difficulty with removal.The user made negative pressure with the nanometer and turned the balloon.The cystoscope was removed from the patient, followed by the balloon catheter."force" was used to remove the balloon and once removed, the balloon catheter was broken.The cystoscope was reinserted, and remains of the balloon were found.The remains were successfully removed with forceps/tweezers.The patient did not require any additional procedures due to this occurrence.According to the initial reporter, the patient did not experience any adverse effects due to this occurrence.
|
|
E1: customer name and address = address line 2: (b)(6).This report includes information known at this time.A follow-up report will be submitted should additional relevant information become available.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|
|
Blank fields on this form indicate the information is unknown, unchanged, or unavailable.Summary of event: as reported, during a balloon dilation of the "left pyelo-ureteral schedule", an advance 18 lp low profile balloon catheter separated.The balloon was advanced over another manufacturer's guidewire and through another manufacturer's cystoscope through the urethra.Another manufacturer's catheter was used for contrast introduction.The balloon was inflated in the left skyle-ureteral junction to fourteen atmospheres one time for three minutes.Once the balloon was completely deflated and returned to ambient pressure, a counterclockwise rotation was used to remove the balloon while maintaining negative pressure.The removal was controlled with microscopy (x-ray).Upon reaching the uretero-vesical junction, the user encountered problems/difficulty with removal.The user made negative pressure with the nanometer and turned the balloon.The cystoscope was removed from the patient, followed by the balloon catheter."force" was used to remove the balloon and once removed, the balloon catheter was broken.The cystoscope was reinserted, and remains of the balloon were found.The remains were successfully removed with forceps/tweezers.The patient did not require any additional procedures due to this occurrence.According to the initial reporter, the patient did not experience any adverse effects due to this occurrence.Corrected information: d4 investigation evaluation: reviews of the complaint history, device history record (dhr), drawing, instructions for use (ifu), and quality control procedures were conducted during the investigation.The complaint device was not returned to cook for investigation.A document-based investigation evaluation was performed.A review of the device history record found no relevant non-conformances on the lot.A review of complaint history found no additional complaints for this lot number.The product ifu states ¿the advance 18lp low-profile pta balloon dilatation catheter has been designed for percutaneous transluminal angioplasty (pta) of lesions in peripheral arteries including internal iliac, renal, popliteal, infrapoptiteal, femoral, iliofemoral, as well as obstructive lesions of native or synthetic arteriovenous dialysis fistulae.¿ a review of the device master record (dmr) concluded that sufficient inspection activities are in place to identify this failure mode prior to distribution.The information provided upon review of the dmr, dhr, and ifu suggests that there is evidence the device was manufactured to specification.There is no evidence of non-conforming devices in-house or in the field.Based on the information provided and the results of the investigation, cook has concluded that off-label use contributed to this event.The ifu states that the pta balloon dilatation catheter has been designed for percutaneous transluminal angioplasty (pta) of lesions in peripheral arteries including internal iliac, renal, popliteal, infrapoptiteal, femoral, iliofemoral, as well as obstructive lesions of native or synthetic arteriovenous dialysis fistulae.Use of this catheter in the ureter is not listed in the product ifu.The risk analysis for this failure mode was reviewed and no additional escalation was required.The appropriate personnel have been notified and cook will continue to monitor for similar events.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|